Deutsche Bank sets Sarepta stock target at $136, cites risks
Deutsche Bank (ETR:DBKGn) initiated coverage of Sarepta Therapeutics (NASDAQ:SRPT), assigning a Hold rating to the ...
Deutsche Bank sets Xenon stock Buy rating, $67 price target
Deutsche Bank (ETR:DBKGn) initiated coverage on Xenon Pharmaceuticals (NASDAQ:XENE) with a Buy rating and a price target of ...
Deutsche Bank Sticks to Their Hold Rating for AstraZeneca (AZN)
Deutsche Bank analyst Emmanuel Papadakis maintained a Hold rating on AstraZeneca (AZN – Research Report) today and set a price target of ...
Deutsche Bank's Q4 Results: Still Trading At A Discount
Deutsche Bank Aktiengesellschaft's Q4 results showed an 8.6% revenue increase but a 17% drop in pre-tax profit. Click here to ...
Honeywell International (NASDAQ:HON) Upgraded to “Buy” at Deutsche Bank Aktiengesellschaft
Deutsche Bank Aktiengesellschaft upgraded shares of Honeywell International (NASDAQ:HON – Free Report) from a hold rating to ...
This Nvidia Supplier's Stock Is Down 30% in 3 Months—Here’s Why Deutsche Bank Says It's Still a Buy
After reaching record highs last year, shares of Monolithic Power Systems have slumped more than 30% since the firm's last earnings report at the end of October, but analysts remain bullish on the ...
Morningstar13d
Deutsche Bank Earnings: Cost Guidance Disappoints; Share Price Assumes a Perfect 2025
Deutsche Bank reported fourth-quarter operating profits of EUR 583 million, missing consensus estimates collected by the bank itself by 38%. Higher operating expenses of EUR 5.276 billion on an ...